The safety of this ingredient has not been documented and substantiated. The Cosmetic Ingredient Review Expert Panel cannot conclude that Benzylparaben is safe for use in cosmetic products until such time that the appropriate safety data have been obtained and evaluated. The data that were available are documented in the report as well as the types of data that are required before a safety evaluation may be undertaken.
References
1.
1. Elder, R. (ed.). (1984). Final report on the safety of methylparaben, propylparaben, butylparaben, and ethylparaben. J. Am. Coll. Toxicol.3(5), 147–209.*
2.
2. EUROPEAN ECONOMIC COMMISSION. (September 14, 1984). Colipa number 7.*
3.
3. COSMETIC, TOILETRY AND FRAGRANCE ASSOCIATION (CTFA). (June 2, 1981). Submission of data by CTFA. Cosmetic ingredient chemical description (2–7–7).*
5. Wilkinson, B., and Moore, R.J. (1982). Harry's Cosmeticology. New York: Chemical Publishing Company, Inc.
6.
6. FOOD AND DRUG ADMINISTRATION (FDA). (December 22, 1981). (a) Ingredients used in each product category. (b) Number of brand name products in each product code. Computer printouts.
7.
7. Ishizeki, Ch. Aoyama, S., Hatta, Y., Fujita, Y., Oda, Y., and Urabe, M. (1955). Studies on food antiseptics. I. Bull. Natl. Hyg. Lab. Tokyo No. 73, 237–243.
8.
8. Loos, H.O. (1935). Zur bekampfung der epidermorphytie der fube und hande mit benzoesaurepraparaben. Arch. Dermat. Syph.173(1), 109–116.
9.
9. Schmidt, E.G., Alvarez de Choudens, J.A., Mcalvain, N.F., Beardsley, J., and Tawab, S.A.A. (1950). A microbiological survey of Cryptococcus neoformans. Arch. Biochem.26, 15–24.
11. Sabalitschka, Th., and Neufeld-Crzellitzer, R. (1954). Zum Verhalten der p-oxybenzoesaureester im menschlichen Korper. Arzneimittelforsch.4, 575–579.
12.
12. Sabalitschka, Th. (1933). Arztl. Apotheker. Krankenhaus. Nr. 10. Cited in Loos, ref. 8, p. 112.
13.
13. CTFA. (January 2, 1985). Submission of unpublished data by CTFA. Acute oral toxicity, acute dermal irritation/corrosion, acute eye irritation/corrosion, and COLIPA summary.*
14.
14. Bubnoff, M.V., Schell, D., and Vogt-Moykoff, J. (1957). Pharmacology of benzoic acid, p-chlorobenzoic acid, p-hydroxybenzoic acid and their esters. II. Arzneimettelforsch.7, 340–344.
15.
15. Kohn, R. (1933). Experimentelle Untersuchungen uber einige Ester der p-oxybenzoesaure. Med. Klin.29, 983–984.
16.
16. Ghirardi, E. (1940). Contributo sperimentale alla conoscenza farmacologica degli esteri superiori dell' acido paraossibenzoica. Arch. Ital. Sci. Farmacol.9, 298–302.
17.
17. Rudner, E.J. (1978). Patch test results of the North American Contact Dermatitis Group. Cosmetics Toiletries.93, 53–54.
18.
18. Cronin, E. (1972). Clinical prediction of patch test results. Trans. St. Johns Hosp. Dermatol. Soc.58(2), 153–161.
20. Meynadier, J.M., Meynadier, J., Colmas, A., Castelain, P.Y., Ducombs, G., Chabeau, G., Lacroix, M., Martin, P., and Ngangn, Z. (1982). Allergie aux conservateurs. Ann. Dermatol. Venereol.109, 1017–1023.
21.
21. Romaguera, C., and Grimalt, F. (1980). Statistical and comparative study of 4,600 patients tested in Barcelona. Contact Dermatitis.6, 309–315.
22.
22. Hjorth, N., and Trolle-Lassen, C. (1963). Skin reactions to ointment bases. Trans. St. Johns Hosp. Dermatol. Soc.49, 127–140.
